日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lnc-PHF3-3 aggravates the chemoresistance of osteosarcoma cells to doxorubicin via the miR-142-3p/HMGB1 axis

Lnc-PHF3-3通过miR-142-3p/HMGB1轴加重骨肉瘤细胞对阿霉素的化疗耐药性

Jingyi Zhou, Mengkai Yang, Weisong Zhao, He Zhang, Lingling Cao, Qi Li, Gangyang Wang

Stable Jumping Control Based on Deep Reinforcement Learning for a Locust-Inspired Robot

基于深度强化学习的蝗虫启发式机器人稳定跳跃控制

Zhou, Qijie; Li, Gangyang; Tang, Rui; Xu, Yi; Wen, Hao; Shi, Qing

Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment

多组学分析识别出具有不同预后的骨肉瘤亚型,提示需要进行分层治疗。

Jiang, Yafei; Wang, Jinzeng; Sun, Mengxiong; Zuo, Dongqing; Wang, Hongsheng; Shen, Jiakang; Jiang, Wenyan; Mu, Haoran; Ma, Xiaojun; Yin, Fei; Lin, Jun; Wang, Chongren; Yu, Shuting; Jiang, Lu; Lv, Gang; Liu, Feng; Xue, Linghang; Tian, Kai; Wang, Gangyang; Zhou, Zifei; Lv, Yu; Wang, Zhuoying; Zhang, Tao; Xu, Jing; Yang, Liu; Zhao, Kewen; Sun, Wei; Tang, Yujie; Cai, Zhengdong; Wang, Shengyue; Hua, Yingqi

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo

安罗替尼通过抑制体内和体外 P-糖蛋白 (PGP1) 功能逆转骨肉瘤的多药耐药性 (MDR)

Gangyang Wang, Lingling Cao, Yafei Jiang, Tao Zhang, Hongsheng Wang, Zhuoying Wang, Jing Xu, Min Mao, Yingqi Hua, Zhengdong Cai, Xiaojun Ma, Shuo Hu, Chenghao Zhou

Personalized medicine modality based on patient-derived xenografts from a malignant transformed GCTB harboring H3F3A G34W mutation

基于携带 H3F3A G34W 突变的恶性转化型 GCTB 患者异种移植瘤的个性化医疗模式

Jiang Yafei, Mu Haoran, Jiang Wenyan, Xue Linghang, Tian Kai, Wang Gangyang, Wang Zhuoying, Han Jing, Yang Mengkai, Tang Yujie, Hua Yingqi, Cai Zhengdong

Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling

溴结构域抑制剂通过抑制 GP130/STAT3 信号传导来减缓骨肉瘤的进展并增强其化学敏感性

Yafei Jiang, Gangyang Wang, Haoran Mu, Xiaojun Ma, Zhuoying Wang, Yu Lv, Tao Zhang, Jing Xu, Jinzeng Wang, Yunqi Li, Jing Han, Mengkai Yang, Zongyi Wang, Ke Zeng, Xinmeng Jin, Song Xue, Mingzhu Yin, Wei Sun, Yingqi Hua, Zhengdong Cai

CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead

CAR-T细胞疗法在癌症治疗中的应用:挑战与未来之路

Zhang, Qingyang; Ping, Jieming; Huang, Zirui; Zhang, Xiaoli; Zhou, Jingyi; Wang, Gangyang; Liu, Shaoyang; Ma, Jianjun

CYT997(Lexibulin) induces apoptosis and autophagy through the activation of mutually reinforced ER stress and ROS in osteosarcoma

CYT997(Lexibulin)通过激活骨肉瘤中相互增强的 ER 应激和 ROS 诱导细胞凋亡和自噬

Zongyi Wang, Fei Yin, Jing Xu, Tao Zhang, Gangyang Wang, Ming Mao, Zhuoying Wang, Wei Sun, Jing Han, Mengkai Yang, Yafei Jiang, Yingqi Hua, Zhengdong Cai

Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma

Raddeanin A 的抗肿瘤活性是由人类骨肉瘤中的 Jun 氨基末端激酶激活和信号转导和转录激活因子 3 抑制介导的

Zhuoying Wang, Jiakang Shen, Wei Sun, Tao Zhang, Dongqing Zuo, Hongsheng Wang, Gangyang Wang, Jing Xu, Fei Yin, Min Mao, Zifei Zhou, Yingqi Hua, Zhengdong Cai

Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo

青萼素A诱导的氧化应激抑制STAT3信号通路的激活并抑制体内外骨肉瘤进展

Min Mao, Tao Zhang, Zhuoying Wang, Hongsheng Wang, Jing Xu, Fei Yin, Gangyang Wang, Mengxiong Sun, Zongyi Wang, Yingqi Hua, Zhengdong Cai